These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9694888)
21. The Molecular Genetics of Mycolic Acid Biosynthesis. PaweŁczyk J; Kremer L Microbiol Spectr; 2014 Aug; 2(4):MGM2-0003-2013. PubMed ID: 26104214 [TBL] [Abstract][Full Text] [Related]
22. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity. Brown AK; Sridharan S; Kremer L; Lindenberg S; Dover LG; Sacchettini JC; Besra GS J Biol Chem; 2005 Sep; 280(37):32539-47. PubMed ID: 16040614 [TBL] [Abstract][Full Text] [Related]
23. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Yuan Y; Zhu Y; Crane DD; Barry CE Mol Microbiol; 1998 Sep; 29(6):1449-58. PubMed ID: 9781881 [TBL] [Abstract][Full Text] [Related]
24. Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG. Parish T; Roberts G; Laval F; Schaeffer M; Daffé M; Duncan K J Bacteriol; 2007 May; 189(10):3721-8. PubMed ID: 17337570 [TBL] [Abstract][Full Text] [Related]
25. Function of heterologous Mycobacterium tuberculosis InhA, a type 2 fatty acid synthase enzyme involved in extending C20 fatty acids to C60-to-C90 mycolic acids, during de novo lipoic acid synthesis in Saccharomyces cerevisiae. Gurvitz A; Hiltunen JK; Kastaniotis AJ Appl Environ Microbiol; 2008 Aug; 74(16):5078-85. PubMed ID: 18552191 [TBL] [Abstract][Full Text] [Related]
26. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. Gavalda S; Léger M; van der Rest B; Stella A; Bardou F; Montrozier H; Chalut C; Burlet-Schiltz O; Marrakchi H; Daffé M; Quémard A J Biol Chem; 2009 Jul; 284(29):19255-64. PubMed ID: 19436070 [TBL] [Abstract][Full Text] [Related]
27. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751 [TBL] [Abstract][Full Text] [Related]
28. Expression, purification, and characterization of the Mycobacterium tuberculosis acyl carrier protein, AcpM. Schaeffer ML; Agnihotri G; Kallender H; Brennan PJ; Lonsdale JT Biochim Biophys Acta; 2001 May; 1532(1-2):67-78. PubMed ID: 11420175 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Mdluli K; Slayden RA; Zhu Y; Ramaswamy S; Pan X; Mead D; Crane DD; Musser JM; Barry CE Science; 1998 Jun; 280(5369):1607-10. PubMed ID: 9616124 [TBL] [Abstract][Full Text] [Related]
30. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Takayama K; Wang C; Besra GS Clin Microbiol Rev; 2005 Jan; 18(1):81-101. PubMed ID: 15653820 [TBL] [Abstract][Full Text] [Related]
31. The solution structure of acyl carrier protein from Mycobacterium tuberculosis. Wong HC; Liu G; Zhang YM; Rock CO; Zheng J J Biol Chem; 2002 May; 277(18):15874-80. PubMed ID: 11825906 [TBL] [Abstract][Full Text] [Related]
32. Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria. Madacki J; Laval F; Grzegorzewicz A; Lemassu A; Záhorszká M; Arand M; McNeil M; Daffé M; Jackson M; Lanéelle MA; Korduláková J J Biol Chem; 2018 Apr; 293(14):5172-5184. PubMed ID: 29472294 [TBL] [Abstract][Full Text] [Related]
33. MadR mediates acyl CoA-dependent regulation of mycolic acid desaturation in mycobacteria. Cooper C; Peterson EJR; Bailo R; Pan M; Singh A; Moynihan P; Nakaya M; Fujiwara N; Baliga N; Bhatt A Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35165190 [No Abstract] [Full Text] [Related]
34. Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis. Boissier F; Bardou F; Guillet V; Uttenweiler-Joseph S; Daffé M; Quémard A; Mourey L J Biol Chem; 2006 Feb; 281(7):4434-45. PubMed ID: 16356931 [TBL] [Abstract][Full Text] [Related]
35. The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis. Sacco E; Covarrubias AS; O'Hare HM; Carroll P; Eynard N; Jones TA; Parish T; Daffé M; Bäckbro K; Quémard A Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14628-33. PubMed ID: 17804795 [TBL] [Abstract][Full Text] [Related]
36. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478 [TBL] [Abstract][Full Text] [Related]
37. Expression and characterization of Rv0447c product, potentially the methyltransferase involved in tuberculostearic acid biosynthesis in Mycobacterium tuberculosis. Meena LS; Kolattukudy PE Biotechnol Appl Biochem; 2013; 60(4):412-6. PubMed ID: 24033595 [TBL] [Abstract][Full Text] [Related]
38. A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates. Liu J; Nikaido H Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4011-6. PubMed ID: 10097154 [TBL] [Abstract][Full Text] [Related]
39. Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice. Barkan D; Hedhli D; Yan HG; Huygen K; Glickman MS Infect Immun; 2012 Jun; 80(6):1958-68. PubMed ID: 22431648 [TBL] [Abstract][Full Text] [Related]
40. Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto- and hydroxy-mycolic acids. Dubnau E; Lanéelle MA; Soares S; Bénichou A; Vaz T; Promé D; Promé JC; Daffé M; Quémard A Mol Microbiol; 1997 Jan; 23(2):313-22. PubMed ID: 9044265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]